1220658004: Ruxolitinib withdrawal syndrome (disorder)

• SNOMED CT Concept\Clinical finding\Disease\Sequela of disorder\Substance withdrawal\Ruxolitinib discontinuation syndrome

Status: current, Defined. Date: 31-May 2022. Module: SNOMED CT core

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
5045760015	Ruxolitinib withdrawal syndrome	en	Synonym	Active	Case insensitive	SNOMED CT core
5045761016	Ruxolitinib discontinuation syndrome	en	Synonym	Active	Case insensitive	SNOMED CT core
5045763018	RDS - ruxolitinib discontinuation syndrome	en	Synonym	Active	Case sensitive	SNOMED CT core
5143577016	Ruxolitinib withdrawal	en	Synonym	Active	Case insensitive	SNOMED CT core
5143578014	Ruxolitinib withdrawal syndrome (disorder)	en	Fully specified name	Active	Case insensitive	SNOMED CT core
5045765013	A characteristic ruxolitinib discontinuation syndrome includes an acute relapse of disease symptoms, splenomegaly, and occasional hemodynamic decompensation. Symptoms can appear from less than 24 hours to up to 3 weeks after the abrupt discontinuation of ruxolitinib.	en	Definition	Active	Case sensitive	SNOMED CT core
5045766014	A characteristic ruxolitinib discontinuation syndrome includes an acute relapse of disease symptoms, splenomegaly, and occasional haemodynamic decompensation. Symptoms can appear from less than 24 hours to up to 3 weeks after the abrupt discontinuation of ruxolitinib.	en	Definition	Active	Case sensitive	SNOMED CT core

Expanded Value Set

Reference Sets

Clinical finding foundation reference set

Problem/Diagnosis reference set

Back to Start